stars 1 stars 2 stars 3

Ascend is a CLIA certified and CAP approved, high-complexity reference lab that provides testing services to help inform cancer treatments. We are dedicated to excellence, innovation, and providing the highest level of service in hematopathology and solid tumor cancer diagnostics. We offer our customers access to powerful and sophisticated test platforms usually available only at universities, national cancer centers, and high-end reference laboratories. These platforms include immunohistochemistry (IHC), flow cytometry, fluorescence in situ hybridization (FISH) and polymerase chain reaction (PCR). Ascend is a division of Ascend Clinical, a privately held company that also provides end-stage renal disease (ESRD) testing through its Ascend Clinical division. Ascend Clinical has been a leader in ESRD testing for over thirty years and has a 98% client satisfaction rate among the nation’s independent dialysis centers. Ascend Clinical was founded in the San Francisco Bay Area in 1984 Achieved and maintained 98% satisfaction rating amongst our clients Currently, Ascend Clinical serves over 670 dialysis facilities, 40,000 patients/month and processes 1,000,000 tubes/month Ascend has offices in Foster City, CA, Redwood City, CA with satellite offices in Denver, CO and Colorado Springs, CO.

Ascend Genomics Questions

The Ascend Genomics annual revenue was $1.5 million in 2026.

Ascend Genomics is based in San Mateo, California.

The NAICS codes for Ascend Genomics are [325, 3254, 32].

The SIC codes for Ascend Genomics are [283, 28].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users